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Volume 53, Number 2 Abstracts 557Table.
Variable No TA TA P
Limbs at risk, No. 128 64 —
Gender (%) 51 71 .16
Age, mean  SD, yrs 69  16 69  14 .1
Rest pain/tissue loss, % 71 94 .0001a
TASC C and D lesions, % 50 61 .17
Mortality, % 0.8 0.0 .1
Morbidity, % 9.4 9.4 .1
Outcomes at 5 years, %
Freedom from recurrent
symptoms
78 70 .04a
Limb salvage 78 69 .04a
Primary patency 59 55 .84
Assisted primary patency 69 79 .33
Secondary patency 71 79 .33
aStatistically significant
Treatment of Type II Endoleaks: Coil Embolization of Lumbar Vessels
Has Poor Long-Term Success
Katherine A. Gallagher, MD, Andrew J. Meltzer, MD, Asad Khan, MD,
Peter Connolly, MD, Fran Aiello, MD, Gautam Shrikhande, MD, Rajeev
Dayal, MD, John Karwowski, MD, Weill Cornell/Columbia University,
New York, NY.
Introduction: The significance of type II endoleak after EVAR is still
controversial. The lack of data for outcomes of intervention in attempts to
seal the leak only obfuscates the issue. The effectiveness and durability of
interventions are important in understanding the meaning of type II en-
doleaks. The purpose of this study was to examine outcomes after interven-
tions for type II endoleaks in our institution.
Methods: We evaluated patients who underwent type II endoleak
treatment at our tertiary care facility from 2001 to 2009. Through aggressive
surveillance imaging, 29 patients showed aneurysm enlargement and type II
endoleak. All patients underwent at least one attempt at percutaneous
intervention. Patients were followed-up postoperatively, both clinically and
radiographically, with a CT angiogram every 3 to 12 months. The outcomes
of patients with expanding type II endoleaks after intervention were ana-
lyzed. Themean postprocedural follow-up was 3.5 years (range, 1-10 years).
Results: A total of 48 interventions on 29 patients (22 men, 7 women;
mean age, 76; range 54-87 years) were performed. Of these, 15 patients
(56%) underwent multiple procedures (2): 9 (31%) underwent two, 5
(17%) had three, and 1 (3.4%) had four separate attempts at treatment.
Three ultimately required elective aortic graft explants. There were no
ruptures in these patients during the time they were followed-up. Seven
patients (24%) had continued endoleak despite multiple treatment attempts.
Of the treatment modalities used, lumbar embolization was the least suc-
cessful, with an 82% failure/recurrence rate. Conversely, IMA coil emboli-
zation had the highest success rate (Table). Three patients had minor
complications (hematoma and wound infection). There were no deaths in
this cohort.
Conclusions: Although initial success is often documented immedi-
ately angiographically, as well as in the short-term, long-term outcomes for
intervention on type II endoleak remain unknown. This study demonstrates
that most patients requiremultiple reinterventions to treat type II endoleaks,
and specifically, lumbar embolization carries a low long-term success rate.
Table. Outcomes based on endoleak intervention
Initial intervention Success Failure Secondary interventi
IMA embolization 8 3 Lumbar embolizatio
IMA embolization
Lumbar embolization 3 14 Lumbar embolizatio
Laparoscopic ligation
Explant
Thrombin gel
IMA embolizationLaparoscopic ligation 0 1 Explantarotid Stenting: The Data of Transcranial Doppler, Cognitive Tests,
nd DWI-MR May Influence Results?
oberto Gattuso, MD, Luigi Irace, MD, Jihad Jabbour, MD, Marco Maria
iuseppe Felli, MD, Federico Faccenna, MD, Antonella Laurito, MD,
lessia Alunno, MD, Anna Castiglione, MD, Bruno Gossetti, MD, Poli-
linico Umberrto, Department of Vascular Surgery, Rome, Italy
Objectives: The purpose of this study was to determine the significance
f microembolic signals (MES) recorded with transcranial Doppler (TCD)
uring carotid artery stenting (CAS). This study was based on analysis of
CD data compared both with changes induced on the brain identified by
iffusion-weighted magnetic resonance imaging (DWI-MR) and with po-
ential neurologic impairment assessed by clinical examination and cognitive
ests.
Methods: From January 2007 to December 2009, 152 patients un-
erwent CAS: 112 were asymptomatic (73.8%) and 40 were symptomatic
26.2%). As assessed by duplex scanning, all carotid stenosis were hemody-
amically significant and plaques had echomorphologic features of stability.
CAS was successfully done in 150 patients (98.7%). Cerebral protection
lter devices were used in all patients. Before the procedure, 60 minutes of
CDmonitoring was performed to detect MES in order to exclude embolic
laques. TCD monitoring was carried out throughout the procedures and
or 60 minutes after. In all patients, neurologic examination associated to
ognitive tests and DWI-MR were carried out preoperatively and postoper-
tively. Statistical analysis was performed by means the binomial test (P 
50) and the Fischer exact test.
Results: There were no deaths. Five minor stokes occurred during the
rocedure, and all were related to40MES; one major stroke was observed
ostoperatively. Fewer than 40 MES were recorded in 97 cases; in this
roup, postoperative DW-MRI showed new ischemic lesions in 18 (18.5%,
 .0009). In 48 patients was recorded MES 40 either during catheter-
zation of carotid arteries and during cerebral protection filter placement (27
atients, group A) or during stent placement and ballooning (21 cases,
roup B). Postoperative DW-MRI showed new ischemic lesions in 21 of 27
atients of group A and in all patients of group B, with a statistically
ignificant correlation. Comparison ofMRI data with those of cognitive tests
howed a statistical significant correlation between DWI lesions and post-
perative cognitive impairment (P .00001). Symptomatic patients suffer-
ng from minor or major strokes had DW-MRI lesions 20 mm2.
Conclusions: Our data suggest that even in selective patients under-
oing CAS, when intraprocedural TCD records 40 MES during stent
eployment, there is a high odds ratio new ischemic lesions will develop as
etected by DW-MRI, combined with postprocedural cognitive impair-
ent.
National Survey of The Use of Anti-Platelet Medications and Prota-
ine During Carotid Endarterectomy and Carotid Artery Stenting:
hat Is the Standard?
lizabeth M. Quiroz, BA, Ross Milner, MD, Loyola University Medical
enter, Maywood, Ill.
Objectives: The use of anticoagulation during carotid endarterectomy
CEA) and carotid artery stenting (CAS) has been standard practice for
any years. However, reversal with protamine sulfate has not been a
ormally standardized process. In our study, we assessed the anticoagulation
herapies most commonly used before, during, and after these procedures.
n addition, we evaluated the percentage of vascular surgeons that perform
arotid artery interventions.
Methods: Members of the Society of Vascular Surgery were sent an
-mail survey by Survey Monkey with 16 multiple-choice questions about
EA and CAS anticoagulation management. The questions addressed the
hoices of antiplatelet therapy before the procedure, assessment of platelet
nhibition before the procedure, anticoagulation therapy during the proce-
Success Failure Subsequent interventions Success Failure
1
1
2 3 Lumbar embolization 2 4
1 2 Explant 1
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February 2011558 Abstractsdure, and the use of protamine. The results were analyzed and used for
comparison between the use of these medications for CEA vs CAS.
Results: Of 2434 recipients who were sent a questionnaire, 653 (27%)
participated in the survey. Of these 653 participants, 649 (99%) stated that
they perform CEA and 598 (93%) perform CAS. Of the 649 vascular
surgeons that perform CEA, 85% use aspirin alone preoperatively. Plavix was
used by 4%, and both were used by 9.7%. Ninety-nine percent use heparin
during the procedure, and 48% use protamine to reverse the heparin dose.
Of the 598 vascular surgeons that performCAS, only 41% use a combination
of aspirin and Plavix before the procedure. Aspirin alone was used by 26.8%
and Plavix alone by 45.3%. Ninety-three percent use heparin during the
procedure (6.2% used bivalirudin), and only 16% reversed the heparin dose
with protamine. Platelet inhibition before either intervention is almost never
assessed (3.5% with CEA and 3.9% with CAS).
Conclusions: These results suggest that there is no difference between
the numbers of vascular surgeons performing carotid endarterectomy com-
pared with carotid artery stent placement. Conversely, there is a substantial
difference in the selection of antiplatelet medications before the two proce-
dures. In addition, there is a large difference in the administration of
protamine after CEA compared with CAS. This survey suggests that there is
no standard practice on the use of preprocedural medications or the use of
protamine sulfate for heparin reversal during carotid procedures.
Carotid Surgery Is the Gold Standard for High-Risk (HRP) Carotid
Artery Intervention: Five-Year Cost-Effectiveness and Quality Stroke-
Free Survival Comparison Between Carotid Endarterectomy (CEA),
Carotid Angioplasty, and Stenting Technique (CAST), and Optimal
Medical Therapy (OMT)
NiamhHynes,MD,MRCS,MMSc Endo, Sherif Sultan,MD, FRCS, FACS,
Western Vascular Institute, Galway, Ireland.
Background: Our aim was to conciliate carotid angioplasty and stent-
ing technique (CAST) with CEA and optimal medical therapy (OMT) in
high-risk patients. Primary end points were stroke, myocardial infarction, or
death. Secondary end points were patency rate, cost-effectiveness, length of
hospital stay, reintervention rate, quality of life, Q-TwiST (Quality-Adjusted
TimeWithout Symptoms of Disease or Toxicity of Treatment), and cost per
quality-adjusted life-year (QALY).
Methods: Between October 2001 and October 2008, 847 patients
were evaluated with carotid stenosis 60%. Predicted probability of receiv-
ing CEA, CAST, and OMTwas tabulated using multiple logistic regressions
to control for comorbidity and anatomic high-risk factors. Propensity scor-
ing adjusted for baseline characteristics and selection bias by matching
covariables, creating a pseudorandomized control design for 306 CEA, 39
CAST, and 275 OMT, of which computer randomization generated 55
CEA, 34 CAS, and 67 OMT. Nineteen (6.3%) had bilateral interventions.
Comorbidity Severity Scores were similar between groups (P  .05)
Results: All interventions were within a mean of 18 days from initial
presentation. Mean age was similar between CEA (68.6 years) and CAST
(70.6 years, P .05) but OMT patients were significantly older (75.4 years)
than CEA (P .01) or CAST patients (P .05). Duplex ultrasound was the
sole preoperative imagingmodality to quantify plaque-typemorphology and
degree of stenosis. After carotid intervention, overall 30-day stroke free
survival rate was 99.1% (95% CI, 99.6%-99.9%). The 5-year stroke-free rate
was 99.1% (95% CI, 99.6%-99.9%), stroke-free survival was 90.6% (95% CI,
85.9%-93.9%), and primary patency was 94.6% (95% CI, 90.5%-97.0%). The
5-year stroke free survival significantly improved with CEA (90.6%) com-
pared with OMT (44.3%, H  .22; 95% CI, .08-.61; P  .0001). Cox
proportional hazards ratio showed age80 years (P .001), female gender
(P  .04), and echolucent plaque material (P  .01) were associated with
reduced stroke free survival. Q-TwiST, and cost per QALY were in favor of
CEA vs CAST (P .05) and significantly improved with CEA vs OMT (P
.0001) and CAST (P  .001).
Conclusions: OMT does not prevent future stroke in patients with
severe carotid artery disease. Indications for CAST are limited, and strict
selection criteria should apply. Contemporary trends verify that stenting
techniques and cerebral protection devices prerequisite device maturity
before it befalls routine clinical practice. CEA is the gold standard in suitable
patients with recently symptomatic carotid artery stenosis, with superior
stroke-free survival rates at 5 years when compared with CAST or OMT.
Characterization of Resident Surgeon Participation During Carotid
Endarterectomy and Impact on Perioperative Outcomes
James Reeves, MD, Gabriela Velazquez-Ramirez, MD, Thomas F. Dodson,
MD, David McClusky, MD, Karthikeshwar Kasirajan, MD, Ravi
Veeraswamy, MD, Atef Salam, MD, Elliot Chaikof, MD, PhD, Matthew A.
Corriere, MD, MS, Emory University School of Medicine, Atlanta, Ga.
Objectives: The impact of resident care on vascular patient outcomes
has not been well characterized. We analyzed resident surgeon participation
during carotid endarterectomy (CEA), procedural characteristics, and asso-
ciations with perioperative outcomes using the 2005-2008 American Col-
f
rege of Surgeons National Surgical Quality Improvement Program (NSQIP)
ata file.
Methods: CEAs were identified using primary CPT codes. Compari-
ons based on resident participation were performed using 2 or Fisher exact
est for categoric variables and t tests or nonparametric methods for contin-
ous variables. Associations with complications (major: stroke, death, or
yocardial infarction; minor: reoperation, reintubation, bleeding, or nerve
njury) were assessed using logistic regression.
Results: Residents were scrubbed for 9937 of 17,542 CEAs analyzed
56.7%). Resident level was categorized as junior (postgraduate year [PGY]
-2) in 20.9%, senior (PGY 3-5) in 52.9%, and fellow (PGY6) in 26.2% of
EAs. Preoperative and procedural data based on resident participation
tatus are reported the Table. Patients undergoing CEA who had a resident
crubbed had a longer mean anesthesia time (197 vs 159 minutes; P 
0001) but shorter hospital stays (39.5% vs 43.8% of patients hospitalized1
ay; P .0001). Multivariable models did not reveal significant associations
etween resident participation and risk of major or minor complications.
Conclusions: Although resident participation during CEA was associ-
ted with longer anesthesia times, no effect on complications was observed
nd length of stay was shorter when residents were scrubbed. Resident
ontributions to postoperative care may favorably impact outcomes, and
ssessment of resident impact should not be limited to procedural factors.
able. Preoperative and procedural data based on
esident participation
Variable
Resident
PAbsent Present
ge, years 71.2 70.5 .0001
eight, kg 80.4 80.6 NS
emale, % 41.8 40.4 NS
iabetes 26.9 27.3 NS
ypertension, % 85.2 85.3 NS
oronary disease, % 37.6 36.4 NS
urrent smoker, % 27.7 27.7 NS
ematocrit, % 39.5 39.5 NS
BC, 103/uL 7.7 7.7 NS
erum creatinine, mg/dL 1.19 1.17 NS
reoperative TIA, % 28.6 28.1 NS
reoperative stroke, % 23.6 24.1 NS
eneral anesthesia, % 84.6 82.3 .0001
SA class  III, % 91.1 89.0 .0001
mergent procedure, % 1.7 1.8 NS
nesthesia time, min 158.9 196.6 .0001
ntra-op transfusion, U 0.02 0.03 NS
he Malignant Course of Carotid Artery Occlusion: Risk Factor and
utcomes
arren Bryan, BA,1 John Carson, MD,2 Qi He, MD,3 Khalil Qato, BA,4
isham Bassiouny, MD,3 Christopher L. Skelly,3 1University of Rochester
chool of Medicine and Dentistry, Rochester, NY; 2University of California,
avis, Mather, Calif; 3University of Chicago Hospitals, Chicago, Ill; 4New
ork Medical College, Valhalla, NY.
Objective: This study evaluated the long-term outcomes of patients
ith carotid artery occlusion and determined risk factors predictive of death,
eurologic event, or contralateral carotid intervention.
Methods: Patients with carotid occlusion shown by duplex ultrasound
maging were retrospectively identified and followed-up between January
002 and June 2010 (mean, 52 months; range, 1-93 months) at a tertiary
are hospital. All had a minimum of three duplex examinations available for
eview. Analysis by 2 was used to determine risk factors for death, neuro-
ogic event, or contralateral intervention. Multivariate Cox proportional
azard analysis was conducted with P values  0.1. Survival was estimated
sing the Kaplan-Meier method (P  .05 significant).
Results: Eighty patients with comorbidities commensurate for a ter-
iary care center were identified and available for analysis. At the initial
ncounter, 30 (38%) were symptomatic, with 23 (29%) having symptoms
eferable to the occluded carotid. During follow-up, 7 (9%) had a neurologic
vent, of which 6 (86%) were referable to the occluded side; 14 (18%)
nderwent a contralateral operation, and 19 (24%) died. Multivariate anal-
sis revealed amaurosis fugax at initial presentation was a risk factor for
ontralateral operation (P .05). Although numerous variables of multives-
el disease were significant with 2 analysis, there was no significant risk
actor associated with neurologic event upon multivariate analysis. Neck
adiation (P  .05) and stenosis or occlusion of the external carotid
